Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment
Abstract
Share and Cite
Nies, K.; Vernooij, R.; Devriese, L.; Venhuizen, J.-H.; Berg, M.t.; Swart, C.; Lammers, L.; Haitjema, S. Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment. Pharmaceutics 2025, 17, 1280. https://doi.org/10.3390/pharmaceutics17101280
Nies K, Vernooij R, Devriese L, Venhuizen J-H, Berg Mt, Swart C, Lammers L, Haitjema S. Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment. Pharmaceutics. 2025; 17(10):1280. https://doi.org/10.3390/pharmaceutics17101280
Chicago/Turabian StyleNies, Kelly, Robin Vernooij, Lot Devriese, Jan-Hendrik Venhuizen, Maarten ten Berg, Christina Swart, Laureen Lammers, and Saskia Haitjema. 2025. "Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment" Pharmaceutics 17, no. 10: 1280. https://doi.org/10.3390/pharmaceutics17101280
APA StyleNies, K., Vernooij, R., Devriese, L., Venhuizen, J.-H., Berg, M. t., Swart, C., Lammers, L., & Haitjema, S. (2025). Chemotherapy-Induced Hematological Toxicity in Patients with Renal or Hepatic Impairment. Pharmaceutics, 17(10), 1280. https://doi.org/10.3390/pharmaceutics17101280